Abstract:Many Ser/Thr protein kinases, to be fully activated, are obligated to introduce a phospho-Ser/Thr in their activation loop. Presently, the similarity of activation loop between two crystal complexes, i.e. glycogen synthase kinase 3 beta (GSK3 beta)-AMPNP and GSK3 beta-sulfate ion complex, indicates that the activation segment of GSK3 beta is preformed requiring neither a phosphorylation event nor conformational changes. GSK3 beta, when participated in glycogen synthesis and Wnt signaling pathways, possesses a unique feature with the preference of such substrate with a priming phosphate. Experimental mutagenesis proved that the residue arginine at amino acid 96 mutations to lysine (R96K) or alanine (R96A) selectively abolish activity on the substrates involved in glycogen synthesis signaling pathway. Based on two solved crystal structures, wild type (WT) and two mutants (R96K and R96A) GSK3 beta-ATP-phospho-Serine (pSer) complexes were modeled. Molecular dynamics simulations and energy analysis were employed to investigate the effect of pSer involvement on the GSK3 beta structure in WT, and the mechanisms of GSK3 beta deactivation due to R96K and R96A mutations. The results indicate that the introduction of pSer to WT GSK3 beta generates a slight lobe closure on GSK3 beta without any remarkable changes, which may illuminate the experimental conclusion, whereas the conformations of GSK3 beta and ATP undergo significant changes in two mutants. As to GSK3 beta, the affected positions distribute over activation loop, alpha-helix, and glycine-rich loop. Based on coupling among the mentioned positions, the allosteric mechanisms for distorted ATP were proposed. Energy decomposition on the residues of activation loop identified the important residues Arg96 and Arg180 in anchoring the phosphate group.

Catalytic activity in vitro of the human protein kinase ASK1 mutants: Experimental and molecular simulation study

Therapeutic potential of ASK1 activators in cancer treatment: Current insights and future directions

Impacts of Mutations on Dynamic Allostery of Adenylate Kinase.

Mechanistic Insights into the Mechanism of Inhibitor Selectivity toward the Dark Kinase STK17B against Its High Homology STK17A

Improved catalytic activity of a novel aspartate kinase by site-directed saturation mutagenesis

Mutation of the Conserved G66 Residue in GS Region Decreased Structural Stability and Activity of Arginine Kinase

Mechanism of Kinase Inactivation and Nonbinding of FRATide to GSK3β Due to K85M Mutation: Molecular Dynamics Simulation and Normal Mode Analysis.

Discovery and Computational Studies of Potent Covalent Kinase Inhibitors with alpha-Substituent Electrophiles Targeting Cysteine

T273 Plays an Important Role in the Activity and Structural Stability of Arginine Kinase.

Imatinib binding to human c-Src is coupled to inter-domain allostery and suggests a novel kinase inhibition strategy

Kinematic analysis of kinases and their oncogenic mutations – Kinases and their mutation kinematic analysis

Allosteric Kinase Inhibitors Reshape MEK1 Kinase Activity Conformations in Cells and In Silico

The Role and Regulation of Apoptosis Signal-Regulated Kinase 1 in Liver Disease

The cryo-EM structure of ASK1 reveals an asymmetric architecture allosterically modulated by TRX1

Integrated in Silico‐in Vitro Analysis of Systematic Kinase Gatekeeper Mutation Effects on Pan‐kinase Inhibitors in Targeted Liver Cancer Therapy

Computational analyses of JAK1 kinase domain: subtle changes in the catalytic cleft influence inhibitor specificity.

Role of phosphorylated Thr-197 in the catalytic subunit of cAMP-dependent protein kinase

Structural basis for the complete loss of GSK3beta catalytic activity due to R96 mutation investigated by molecular dynamics study.

Exploring the interaction between human focal adhesion kinase and inhibitors: a molecular dynamic simulation and free energy calculations

Mutation of the Conserved Asp122 in the Linker Impedes Creatine Kinase Reactivation and Refolding